1. Home
  2. NVNO vs BEDU Comparison

NVNO vs BEDU Comparison

Compare NVNO & BEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNO
  • BEDU
  • Stock Information
  • Founded
  • NVNO 1987
  • BEDU 1994
  • Country
  • NVNO United States
  • BEDU United Kingdom
  • Employees
  • NVNO N/A
  • BEDU N/A
  • Industry
  • NVNO Medical/Dental Instruments
  • BEDU Other Consumer Services
  • Sector
  • NVNO Health Care
  • BEDU Real Estate
  • Exchange
  • NVNO Nasdaq
  • BEDU Nasdaq
  • Market Cap
  • NVNO 41.0M
  • BEDU 44.9M
  • IPO Year
  • NVNO N/A
  • BEDU 2017
  • Fundamental
  • Price
  • NVNO $3.65
  • BEDU $1.51
  • Analyst Decision
  • NVNO
  • BEDU
  • Analyst Count
  • NVNO 0
  • BEDU 0
  • Target Price
  • NVNO N/A
  • BEDU N/A
  • AVG Volume (30 Days)
  • NVNO 76.7K
  • BEDU 13.9K
  • Earning Date
  • NVNO 05-01-2025
  • BEDU 04-28-2025
  • Dividend Yield
  • NVNO N/A
  • BEDU N/A
  • EPS Growth
  • NVNO N/A
  • BEDU N/A
  • EPS
  • NVNO N/A
  • BEDU N/A
  • Revenue
  • NVNO N/A
  • BEDU $224,321,752.00
  • Revenue This Year
  • NVNO N/A
  • BEDU N/A
  • Revenue Next Year
  • NVNO $409.09
  • BEDU N/A
  • P/E Ratio
  • NVNO N/A
  • BEDU N/A
  • Revenue Growth
  • NVNO N/A
  • BEDU N/A
  • 52 Week Low
  • NVNO $2.03
  • BEDU $1.35
  • 52 Week High
  • NVNO $6.48
  • BEDU $2.42
  • Technical
  • Relative Strength Index (RSI)
  • NVNO 71.64
  • BEDU 42.49
  • Support Level
  • NVNO $2.61
  • BEDU $1.40
  • Resistance Level
  • NVNO $3.97
  • BEDU $1.94
  • Average True Range (ATR)
  • NVNO 0.22
  • BEDU 0.11
  • MACD
  • NVNO 0.11
  • BEDU -0.00
  • Stochastic Oscillator
  • NVNO 80.00
  • BEDU 20.41

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

About BEDU Bright Scholar Education Holdings Limited each representing four

Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.

Share on Social Networks: